Benuvia Therapeutics Inc.
444 South Ellis Street
Chandler, AZ 85224
Phone: (480) 581-1385Website: https://www.benuvia.com/
- INSYS Therapeutics Receives Complete Response Letter from FDA for Buprenorphine NDA
27 July 2018
- INSYS Therapeutics Confirms Outcome of FDA Advisory Committee Meeting on Buprenorphine Sublingual Spray
22 May 2018
- FDA Accepts New Drug Application (NDA) for Buprenorphine Sublingual Spray from INSYS Therapeutics
6 December 2017
- INSYS Therapeutics Files New Drug Application (NDA) for Buprenorphine Sublingual Spray with FDA
29 September 2017
- Insys Therapeutics Announces FDA Approval of Syndros (dronabinol) Oral Solution
5 July 2016
Drugs Associated with Benuvia Therapeutics Inc.
Benuvia Therapeutics Inc. manufactures, markets and/or distributes 1 drug in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.